Pablo Escriba PhD

Since his early postdoctoral stages in New York, Kansas City, and Charleston (USA), Escribá has been a pioneering researcher in lipids, particularly those of the cell membrane and their interactions with membrane proteins. He discovered “lipid switches”, drastic changes in the membrane composition caused by lipid alterations that trigger disease processes, such as the growth of certain tumors.

Escribá has also worked at the University of Alicante, the University of Valencia, the University of Geneva (Switzerland), the Biological Research Center of Szeged (Hungary), and the Cajal Institute of the Spanish National Research Council (CSIC). He is currently a professor of Cell Biology at the University of the Balearic Islands (UIB), and it was here that he realized that he was generating knowledge with the potential to change the lives of patients of multiple diseases. Thus arose the momentum behind Laminar Pharma, a spin-off company from the UIB he founded in 2006 to develop a promising new therapeutic strategy based on all this knowledge: mesotherapy.